1 / 18

*Presented by: Bryan R. Garner, PhD Senior Implementation Research Scientist RTI International

A motivational interviewing-based brief intervention reduces substance use and increases antiretroviral therapy (ART) medication adherence.

jsouthwell
Download Presentation

*Presented by: Bryan R. Garner, PhD Senior Implementation Research Scientist RTI International

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A motivational interviewing-based brief intervention reduces substance use and increases antiretroviral therapy (ART) medication adherence *Bryan Garner, Stephen Tueller, Michael Bradshaw, Kate Speck, Denna Vandersloot, Heather Gotham, Michael Chaple, Liz Ball, Alyssa Wolfe, and Steve Martino *Presented by: Bryan R. Garner, PhD Senior Implementation Research Scientist RTI International 3040 E. Cornwallis Rd. Research Triangle Park, NC 27709-2194 Phone: (919) 597-5159 Email: bgarner@rti.org

  2. Disclosures • The authors have no financial interests to disclose. • This continuing education activity is managed and accredited by AffinityCE/Professional Education Services Group in cooperation with HRSA and LRG. PESG, HRSA, LRG and all accrediting organization do not support or endorse any product or service mentioned in this activity. • PESG, HRSA, and LRG staff as well as planners and reviewers have no relevant financial or nonfinancial interest to disclose. • Commercial Support was not received for this activity.

  3. Learning Objectives • Improve understanding about current efforts to address substance use among individuals living with HIV/AIDS • Improve understanding about how efforts to address substance use may also help increase adherence to antiretroviral therapy • Improve understanding about the effectiveness of a motivational interviewing-based brief intervention for substance use that can be implemented by case-management staff

  4. Implementing a motivational interviewing-based brief intervention for substance use within HIV service settings:The SAT2HIV Project

  5. Implementing a motivational interviewing-based brief intervention for substance use within HIV service settings:The SAT2HIV Project’s MIBI Experiment

  6. Implementing a motivational interviewing-based brief intervention for substance use within HIV service settings:Conceptual Overview of MIBI Experiment

  7. Participant Flow Chart

  8. Participant Inclusion and Exclusion Criteria • Inclusion Criteria • Living with HIV/AIDS • 18+ years of age, • Acknowledging use of at least one substance within the past 28 days and endorsing two or more substance use disorder symptoms during the past 12 months. • Exclusion Criteria • The only study exclusion criterion was not being able to speak English.

  9. Participant Flow Chart (continued)

  10. The SAT2HIV Project’s motivational interviewing-based brief intervention (MIBI)

  11. Visual illustration of the SAT2HIV Project’s motivational interviewing-based brief intervention (MIBI)

  12. Implementing a motivational interviewing-based brief intervention for substance use within HIV service settings:Conceptual Overview of MIBI Experiment (cont.)

  13. Methods Sample • 824 individuals living with HIV/AIDS and reporting recent substance use, clustered within 61 staff that were clustered within 34 organizations. • 415 (50.4%) randomized to Usual Care (UC) • 409 (49.6%) randomized to Usual Care + Brief Intervention (UC+BI) Outcomes • Days of primary substance use - A continuous measure (ranges from 0 - 28) of the number of days participants used their primary substance during the past 28 days. • Number of substance-related problems - A continuous measure (ranges from 0 - 11) of the number of substance use disorder symptoms participants had during the past 28 days. • Analytic sample and plan • Data from 687 client participants (83% follow-up rate) were used in adjusted multilevel regression analyses to examine the relationship between condition assignment and each respective outcome.

  14. Results: Primary Substance Use*

  15. Results: Medication Non-Adherence*

  16. Conclusions • Results provide evidence supporting the effectiveness of a one-time 20-30 MIBI for substance use as an adjunct to usual care within ASOs. • Need to try better understand why the effect of the MIBI differed by race and age.

  17. Thank you! Bryan R. Garner, PhD Senior Implementation Research Scientist RTI International 3040 E. Cornwallis Rd. Research Triangle Park, NC 27709-2194 Phone: (919) 597-5159 Email: bgarner@rti.org

  18. Obtaining CME/CE Credit If you would like to receive continuing education credit for this activity, please visit: http://ryanwhite.cds.pesgce.com

More Related